CELL INTELLIGENCE · 肿瘤细胞治疗研究

儿童慢性活动性 EB 病毒感染按优势感染淋巴细胞亚群管理后的长期结局

Long-term outcomes of chronic active Epstein-Barr virus infection in childhood after dominantly infected lymphocyte subpopulation management.

EBV 感染淋巴细胞谱分析指导 CAEBV 的长期无 HCT 控制。CD4+T 细胞型 CAEBV 需及时而非择期进行 HCT，以防疾病进展和转化。

AML/MDS 细胞治疗的最新进展

Recent advances in cell therapy for AML/MDS.

CD19 CAR-T 细胞疗法治疗活动性玻璃体视网膜淋巴瘤的疗效

Efficacy of CD19 CAR T-cell therapy in active vitreoretinal lymphoma.

日本 CAR-T 细胞产品的现状和问题：监管视角

Current status and issues with CAR-T cell products in Japan: a regulatory perspective.

具有 CD38(-)CD73(-)Tim-3(-)HLA-DR(+) 表型的 CAR-T 细胞预测 tisagenlecleucel 治疗 B 细胞前体 ALL 的疗效

CAR-T cells with the CD38(-)CD73(-)Tim-3(-)HLA-DR(+) phenotype predict the efficacy of tisagenlecleucel as a treatment for B cell precursor ALL.

类适应性 CAR-iPSC-CD4⁺ T 细胞在持续控制急性淋巴细胞白血病中优于 CD8⁺ 对应细胞

Adaptive-like CAR-iPSC-CD4⁺ T cells outperform CD8⁺ counterparts in sustained ALL control.

尽管与原发性 CD4 T 细胞不完全相同，iPSC 衍生的 CD4 T 细胞重现了关键功能优势，尤其是持续的抗肿瘤活性，支持其作为下一代 CAR-T 治疗的可再生、现货型来源的价值。

溶瘤病毒与 CAR-T 细胞基因治疗的进展及治疗相关分组

Advances in Gene Therapy with Oncolytic Viruses and CAR-T Cells and Therapy-Related Groups.

选择性 JAK2 通路抑制增强 CD19 CAR-T 细胞的抗白血病功能

Selective JAK2 pathway inhibition enhances anti-leukemic functionality in CD19 CAR-T cells.

一例伴视网膜色素变性样眼底表现的儿童急性淋巴细胞白血病

A Case of Childhood Acute Lymphoblastic Leukemia With Retinitis Pigmentosa-like Fundus Findings.

新型 CD26 靶向 CAR-T 细胞疗法用于 CD26 表达 T 细胞恶性肿瘤的开发

Development of a Novel CD26-Targeted Chimeric Antigen Receptor T-Cell Therapy for CD26-Expressing T-Cell Malignancies.